Nebenwirkungen · Bonviva
Bonviva 150 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 7
HOS-112253 · Präparat HOS-093629
Metabolism and hypocalcaemia nutrition disorders Nervous system Headache Dizziness disorders Eye disorders Ocular inflammation* † Gastrointestinal Oesophagitis, Oesophagitis Duodenitis disorders* Gastritis, including Gastro oesophageal oesophageal ulcerations or reflux disease, strictures and Dyspepsia, dysphagia, Diarrhoea, Vomiting, Abdominal Flatulence pain, Nausea Skin and Rash Angioedema, Stevens-Johnson subcutaneous Face oedema, Syndrome†, tissues disorders Urticaria Erythema Multiforme†, Dermatitis Bullous† Musculoskeletal Arthralgia, Back pain Atypical Osteonecrosis of Atypical and connective Myalgia, subtrochanteri jaw*† fractures of tissue disorders Musculoskelet c and Osteonecrosis of long bones al pain, diaphyseal the external other than Muscle cramp, femoral auditory canal the femur Musculoskelet fractures† (bisphosphonate al stiffness class adverse reaction)† General Influenza like Fatigue disorders and illness* administration site conditions *See further information below †Identified in post-marketing experience.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-04-08T10:53:00Z · SHA-256 e5f8c4ff43097950aaf87f206da02f216225cdebe782032e0b294bf7f7d5e590 · Passage e4bfebe9bfe159456a00a41c11d89efdc6d01be5a86b2387ea1c62d167266cb4 · Zeichen 2378–4660 im Abschnitt